Porter James Richard — SEC Form 4 filings
SEC reporting owner CIK 1862900. 24 Form 4 filings on record with FilingPulse; latest filed 2026-07-15.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2024-01-09 to 2026-07-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 67 legs across 20 filings — 545,734 shares, $47,898,816 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 61.
- Largest priced transaction: sale of 30,000 shares @ $123.72 ($3,711,600) in Nuvalent, Inc., filed 2026-07-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Nuvalent, Inc. (NUVL) | President and CEO, Director | 24 | — | 67 legs · 545,734 sh · $47,898,816 | 61 |
Form 4 filings — Porter James Richard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-15 | 4 | Nuvalent, Inc. (NUVL) | Code (U): 203,529 @ $124 · Disposition to issuer (D): 121,350 · Grant/award (A): 40,025 @ $0 · Disposition to issuer (D): 40,025 · Disposition to issuer (D): 508,942 (derivative) · Disposition to issuer (D): 49,401 (derivative) · +7 more | EDGAR |
| 2026-07-08 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 30,000 @ $18.93 · Sale (S): 30,000 @ $123.72 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 30,000 @ $18.93 · Sale (S): 12,495 @ $87.97 · Sale (S): 14,469 @ $88.79 · Sale (S): 3,036 @ $89.63 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-05-06 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 30,000 @ $18.93 · Sale (S): 1,699 @ $98.54 · Sale (S): 1,408 @ $99.77 · Sale (S): 7,429 @ $101.48 · Sale (S): 17,353 @ $102.10 · Sale (S): 2,111 @ $102.88 · +1 more | EDGAR |
| 2026-04-08 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 13,714 @ $18.93 · Option exercise (M): 16,286 @ $27.85 · Sale (S): 11,354 @ $103.21 · Sale (S): 12,425 @ $103.78 · Sale (S): 6,121 @ $104.78 · Sale (S): 100 @ $105.60 · +2 more | EDGAR |
| 2026-03-10 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 30,000 @ $27.85 · Sale (S): 13,585 @ $98.59 · Sale (S): 16,015 @ $99.29 · Sale (S): 400 @ $100.19 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Nuvalent, Inc. (NUVL) | Sale (S): 3,679 @ $96.06 · Sale (S): 4,727 @ $96.85 · Sale (S): 8,147 @ $97.96 · Sale (S): 1,337 @ $98.52 · Sale (S): 3,963 @ $96.75 · Sale (S): 4,905 @ $97.33 · +3 more | EDGAR |
| 2025-12-23 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 57,000 @ $0.65 · Option exercise (M): 57,000 (derivative) @ $0 | EDGAR |
| 2025-10-17 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $18.93 · Sale (S): 11,310 @ $90.01 · Sale (S): 13,876 @ $90.91 · Sale (S): 1,114 @ $92.19 · Sale (S): 700 @ $92.63 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2025-09-17 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $18.93 · Sale (S): 8,823 @ $78.42 · Sale (S): 16,080 @ $79.30 · Sale (S): 2,097 @ $80.12 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $18.93 · Sale (S): 20,035 @ $75.22 · Sale (S): 6,865 @ $75.98 · Sale (S): 100 @ $76.90 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $18.93 · Sale (S): 5,403 @ $81.64 · Sale (S): 19,997 @ $82.31 · Sale (S): 1,496 @ $83.94 · Sale (S): 104 @ $84.53 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $27.85 · Sale (S): 15,199 @ $76.66 · Sale (S): 11,601 @ $77.26 · Sale (S): 200 @ $78.22 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $27.85 · Sale (S): 15,176 @ $69.28 · Sale (S): 11,489 @ $69.99 · Sale (S): 335 @ $70.77 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2025-04-17 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $27.85 · Sale (S): 10,987 @ $68.31 · Sale (S): 11,060 @ $69.05 · Sale (S): 4,465 @ $70.05 · Sale (S): 488 @ $70.73 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2025-03-19 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $27.85 · Sale (S): 10,036 @ $75.29 · Sale (S): 16,363 @ $76.20 · Sale (S): 601 @ $76.69 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $27.85 · Sale (S): 26,200 @ $78.44 · Sale (S): 800 @ $79.01 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $27.85 · Sale (S): 6,307 @ $74.94 · Sale (S): 9,358 @ $75.51 · Sale (S): 5,493 @ $76.65 · Sale (S): 5,842 @ $77.28 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Nuvalent, Inc. (NUVL) | Grant/award (A): 56,250 @ $0 · Sale (S): 4,962 @ $78.28 · Sale (S): 2,979 @ $79.33 · Sale (S): 9,360 @ $80.54 · Grant/award (A): 112,500 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 22,000 @ $0.65 · Option exercise (M): 22,000 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $27.85 · Sale (S): 18,969 @ $86.46 · Sale (S): 8,031 @ $86.96 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $27.85 · Sale (S): 11,543 @ $87.08 · Sale (S): 6,068 @ $87.95 · Sale (S): 8,278 @ $88.87 · Sale (S): 1,111 @ $89.98 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2024-10-17 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 27,000 @ $27.85 · Sale (S): 26,186 @ $102.26 · Sale (S): 814 @ $103.01 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | Nuvalent, Inc. (NUVL) | Grant/award (A): 112,800 @ $0 · Grant/award (A): 161,100 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1862900 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →